| __timestamp | Bausch Health Companies Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 382096000000 |
| Thursday, January 1, 2015 | 582800000 | 345927000000 |
| Friday, January 1, 2016 | 455000000 | 312303000000 |
| Sunday, January 1, 2017 | 366000000 | 325441000000 |
| Monday, January 1, 2018 | 414000000 | 368298000000 |
| Tuesday, January 1, 2019 | 471000000 | 492381000000 |
| Wednesday, January 1, 2020 | 452000000 | 455833000000 |
| Friday, January 1, 2021 | 465000000 | 526087000000 |
| Saturday, January 1, 2022 | 529000000 | 633325000000 |
| Sunday, January 1, 2023 | 604000000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, innovation is the lifeblood of progress. Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc. are two titans in this arena, each with a distinct approach to research and development (R&D) investment. Over the past decade, Takeda has consistently outpaced Bausch Health, investing nearly 1000 times more in R&D annually. In 2023, Takeda's R&D expenses reached a staggering 730 billion yen, marking a 91% increase since 2014. In contrast, Bausch Health's investment grew by 145% over the same period, peaking at 604 million dollars. This disparity highlights Takeda's aggressive strategy to lead in pharmaceutical innovation. As we look to the future, the question remains: will Bausch Health close the gap, or will Takeda continue to dominate the innovation landscape?
Research and Development Expenses Breakdown: Pfizer Inc. vs Takeda Pharmaceutical Company Limited
Amgen Inc. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Sanofi and Takeda Pharmaceutical Company Limited
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs BioMarin Pharmaceutical Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Sarepta Therapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Amphastar Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and Xencor, Inc.
Research and Development Expenses Breakdown: Alnylam Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Bausch Health Companies Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Bausch Health Companies Inc.
Bausch Health Companies Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Bausch Health Companies Inc. and Novavax, Inc.